SEAR D: Cost effectiveness results for Cervical cancer
This Table provides summary results of the total population-level costs, effects and cost-effectiveness for the selected WHO sub-region and risk factor / disease for the year 2005.
KEY
I$ - International Dollars
Program Costs include costs of administration, media, training etc
Patient Costs include costs of hospital visits, drugs, etc
Incremental cost-effectiveness ratio (ICER) is defined as the incremental change in cost, divided by the incremental change in effectiveness. ICERs are reported for the successive set of interventions that would be selected at expanding levels of resource availability, starting with the intervention with the lowest cost per DALY averted, then moving to the next most cost-effective combination intervention out of the remaining available set of interventions.
Dominated is used to denote an intervention that is more costly and/or less effective than other, more efficient (single or combined) interventions; i.e. dominated interventions do not appear on the expansion path of most cost-effective strategies.
- Published abstract / research report
-
Excel Spreadsheet
xls, 52kb
Download this table in excel
| Interventions:Codes_and_Descriptions | Coverage | Cost per year (I$, millions) per one million_population [i.e. cost per capita] | % Program costs | % Patient costs | DALYs averted per year per one million_population | Average Cost per DALY averted | Incremental Cost per DALY averted |
| CVC-1: Annual Papanicolau smear test [PAP] to persons aged 20-65 with lesion removal only | 95% | 0.95 | 26% | 74% | 276 | 3,424 | Dominated |
| CVC-2: Tri-annual PAP smear to persons aged 20-65with lesion removal only | 95% | 0.54 | 17% | 83% | 238 | 2,273 | Dominated |
| CVC-3: Visual inspection with acid [VIA] at age 40 with lesion removal only | 95% | 0.06 | 25% | 75% | 124 | 458 | Dominated |
| CVC-4: Treatment [Rx] of invasive cancer (Surgery &/or Chemotherapy &/or Radiotherapy) | 95% | 0.27 | 0% | 100% | 1,507 | 182 | 477 |
| CVC-5: Annual PAP smear to persons aged 20-65 with lesion removal and cancer treatment | 95% | 1.22 | 21% | 79% | 1,766 | 688 | Dominated |
| CVC-6: Tri-annual PAP smear to persons aged 20-65 with lesion removal and cancer treatment. | 95% | 0.84 | 11% | 89% | 1,744 | 480 | Dominated |
| CVC-7: VIA at age 40 with lesion removal and cancer treatment. | 95% | 0.48 | 3% | 97% | 1,765 | 269 | 1,240 |
| CVC-8: PAP smear every 5 years to persons aged 20-65 with lesion removal only | 95% | 0.36 | 17% | 83% | 220 | 1,617 | Dominated |
| CVC-9: PAP smear every 5 years to persons aged 20-65 with lesion removal and cancer treatment | 95% | 0.68 | 9% | 91% | 1,722 | 392 | Dominated |
| CVC-10: Annual PAP smear in ages 20-30, then annual PAP & HPV concurrent test from 30-65 with lesion removal only | 95% | 2.56 | 10% | 90% | 287 | 8,907 | Dominated |
| CVC-11: Annual PAP smear in ages 20-30, then annual PAP & HPV concurrent test from 30-65 with lesion removal and cancer treatment | 95% | 2.72 | 6% | 94% | 1,793 | 1,515 | Dominated |
| CVC-12: Tri-Annual PAP smear in ages 20-30, then Tri-annual PAP & HPV concurrent test from 30-65 with lesion removal only | 95% | 1.09 | 5% | 95% | 255 | 4,283 | Dominated |
| CVC-13: Tri-Annual PAP smear in ages 20-30, then Tri-annual PAP & HPV concurrent test from 30-65 with lesion removal and cancer treatment | 95% | 1.32 | 1% | 99% | 1,763 | 748 | Dominated |
| CVC-14: Five Yearly PAP smear in ages 20-30, then Five Yearly PAP & HPV concurrent test from 30-65 with lesion removal only | 95% | 0.69 | 6% | 94% | 242 | 2,845 | Dominated |
| CVC-15: Five Yearly PAP smear in ages 20-30, then Five Yearly PAP & HPV concurrent test from 30-65 with lesion removal and cancer treatment | 95% | 0.98 | 4% | 96% | 1,746 | 564 | Dominated |
| CVC-16: PAP smear at ages 35,40,45 with lesion removal only | 95% | 0.10 | 15% | 85% | 170 | 608 | Dominated |
| CVC-17: PAP smear at ages 35,40,45 with lesion removal and cancer treatment | 95% | 0.55 | 3% | 97% | 1,803 | 303 | 2,886 |
| CVC-18: HPV test at ages 35,40,45 with lesion removal only | 95% | 0.36 | 4% | 96% | 187 | 1,954 | Dominated |
| CVC-19: HPV test at ages 35,40,45 with lesion removal and cancer treatment | 95% | 0.76 | 2% | 98% | 1,800 | 423 | Dominated |
| CVC-20: VIA inspection at ages 35,40,45 with lesion removal only | 95% | 0.13 | 12% | 88% | 182 | 714 | Dominated |
| CVC-21: VIA inspection at ages 35,40,45 with lesion removal and cancer treatment | 95% | 0.53 | 3% | 97% | 1,796 | 294 | 1,719 |
| CVC-22: PAP at age 40 with lesion removal only | 95% | 0.04 | 22% | 78% | 111 | 384 | Dominated |
| CVC-23: PAP at age 40 with lesion removal and cancer treatment | 95% | 0.46 | 2% | 98% | 1,755 | 264 | 757 |
| CVC-24: HPV test at age 40 with lesion removal only | 95% | 0.14 | 7% | 93% | 130 | 1,091 | Dominated |
| CVC-25: HPV test at age 40 with lesion removal and cancer treatment | 95% | 0.56 | 2% | 98% | 1,770 | 315 | Dominated |
| CVC-26: WANING HPV vaccination at age 12 costing $0.60 per dose | 95% | 0.06 | 6% | 94% | 217 | 284 | Dominated |
| CVC-27: WANING HPV vaccination at age 12 costing $0.60 per dose + Rx | 95% | 0.52 | 1% | 99% | 1,679 | 311 | Dominated |
| CVC-28: WANING HPV vaccination at age 12 costing $2.00 per dose | 95% | 0.13 | 3% | 97% | 217 | 591 | Dominated |
| CVC-29: WANING HPV vaccination at age 12 costing $2.00 per dose + Rx | 95% | 0.60 | 1% | 99% | 1,679 | 355 | Dominated |
| CVC-30: PAP(1,20,65)+Waning HPV at age 12 costing $0.60 per dose | 95% | 0.90 | 17% | 83% | 387 | 2,329 | Dominated |
| CVC-31: PAP(3,20,65)+Waning HPV at age 12 costing $0.60 per dose | 95% | 0.56 | 11% | 89% | 368 | 1,522 | Dominated |
| CVC-32: VIA at age 40 +Waning HPV at age 12 costing $0.60 per dose | 95% | 0.11 | 10% | 90% | 267 | 393 | Dominated |
| CVC-33: PAP(1,20,65)+Waning HPV at age 12 costing $0.60 per dose+Rx | 95% | 1.17 | 13% | 87% | 1,830 | 639 | Dominated |
| CVC-34: PAP(3,20,65)+Waning HPV at age 12 costing $0.60 per dose+Rx | 95% | 0.85 | 7% | 93% | 1,822 | 467 | 16,051 |
| CVC-35: VIA at age 40 +Waning HPV at age 12 costing $0.60 per dose+Rx | 95% | 0.50 | 2% | 98% | 1,717 | 293 | Dominated |
| CVC-36: PAP(5,20,65)+Waning HPV at age 12 costing $0.60 per dose | 95% | 0.39 | 10% | 90% | 355 | 1,088 | Dominated |
| CVC-37: PAP(5,20,65)+Waning HPV at age 12 costing $0.60 per dose+Rx | 95% | 0.70 | 6% | 94% | 1,805 | 389 | Dominated |
| CVC-38: PAP (1,20,30) & PAP/HPV(1,30,65)+Waning HPV at age 12 costing $0.60 per dose | 95% | 2.51 | 6% | 94% | 394 | 6,371 | Dominated |
| CVC-39: PAP (1,20,30) & PAP/HPV(1,30,65)+Waning HPV at age 12 costing $0.60 per dose + Rx | 95% | 2.77 | 6% | 94% | 1,854 | 1,493 | 81,629 |
| CVC-40: PAP (3,20,30) & PAP/HPV(3,30,65)+Waning HPV at age 12 costing $0.60 per dose | 95% | 1.14 | 5% | 95% | 379 | 3,018 | Dominated |
| CVC-41: PAP (3,20,30) & PAP/HPV(3,30,65)+Waning HPV at age 12 costing $0.60 per dose + Rx | 95% | 1.41 | 4% | 96% | 1,837 | 770 | 36,764 |
| CVC-42: PAP (5,20,30) & PAP/HPV(5,30,65)+Waning HPV at age 12 costing $0.60 per dose | 95% | 0.74 | 5% | 95% | 371 | 2,001 | Dominated |
| CVC-43: PAP (5,20,30) & PAP/HPV(5,30,65)+Waning HPV at age 12 costing $0.60 per dose + Rx | 95% | 1.03 | 4% | 96% | 1,824 | 567 | Dominated |
| CVC-44: PAP (35,40,45)+Waning HPV at age 12 costing $0.60 per dose | 95% | 0.16 | 11% | 89% | 296 | 529 | Dominated |
| CVC-45: PAP (35,40,45)+Waning HPV at age 12 costing $0.60 per dose+Rx | 95% | 0.58 | 3% | 97% | 1,741 | 333 | Dominated |
| CVC-46: HPV (35,40,45)+Waning HPV at age 12 costing $0.60 per dose | 95% | 0.42 | 4% | 96% | 303 | 1,377 | Dominated |
| CVC-47: HPV (35,40,45)+Waning HPV at age 12 costing $0.60 per dose+Rx | 95% | 0.80 | 2% | 98% | 1,747 | 456 | Dominated |
| CVC-48: VIA (35,40,45)+Waning HPV at age 12 costing $0.60 per dose | 95% | 0.42 | 4% | 96% | 301 | 1,403 | Dominated |
| CVC-49: VIA (35,40,45)+Waning HPV at age 12 costing $0.60 per dose+Rx | 95% | 0.57 | 3% | 97% | 1,745 | 324 | Dominated |
| CVC-50: PAP at age 40 +Waning HPV at age 12 costing $0.60 per dose | 95% | 0.10 | 11% | 89% | 262 | 365 | Dominated |
| CVC-51: PAP at age 40 +Waning HPV at age 12 costing $0.60 per dose + Rx | 95% | 0.49 | 2% | 98% | 1,712 | 289 | Dominated |
| CVC-52: HPV test at age 40 + waning HPV at age 12 costing $0.60 per dose | 95% | 0.19 | 5% | 95% | 270 | 719 | Dominated |
| CVC-53: HPV test at age 40 + waning HPV at age 12 costing $0.60 per dose + Rx | 95% | 0.59 | 2% | 98% | 1,718 | 344 | Dominated |
| CVC-54: Annual PAP smear to persons aged 20-65 with lesion removal only. | 80% | 0.76 | 22% | 78% | 233 | 3,281 | Dominated |
| CVC-55: Tri-annual PAP smear to persons aged 20-65 with lesion removal only. | 80% | 0.48 | 14% | 86% | 201 | 2,391 | Dominated |
| CVC-56: VIA at age 40 with lesion removal only. | 80% | 0.05 | 22% | 78% | 105 | 506 | Dominated |
| CVC-57: Treatment of invasive cancer consisting of Surgery &/or Chemotherapy &/or Radiotherapy | 80% | 0.18 | 0% | 100% | 965 | 183 | Dominated |
| CVC-58: Annual PAP smear to persons aged 20-65 with lesion removal and cancer treatment | 80% | 0.94 | 18% | 82% | 1,248 | 753 | Dominated |
| CVC-59: Tri-annual PAP smear to persons aged 20-65 with lesion removal and cancer treatment. | 80% | 0.67 | 10% | 90% | 1,225 | 549 | Dominated |
| CVC-60: VIA at age 40 with lesion removal and cancer treatment. | 80% | 0.36 | 3% | 97% | 1,573 | 229 | Dominated |
| CVC-61: PAP smear every 5 years to persons aged 20-65 with lesion removal only. | 80% | 0.32 | 14% | 86% | 185 | 1,716 | Dominated |
| CVC-62: PAP smear every 5 years to persons aged 20-65 with lesion removal and cancer treatment | 80% | 0.53 | 8% | 92% | 1,208 | 436 | Dominated |
| CVC-63: Annual PAP smear in ages 20-30, then annual PAP & HPV concurrent test from 30-65 with lesion removal only | 80% | 2.12 | 8% | 92% | 242 | 8,770 | Dominated |
| CVC-64: Annual PAP smear in ages 20-30, then annual PAP & HPV concurrent test from 30-65 with lesion removal and cancer treatment | 80% | 2.22 | 5% | 95% | 1,266 | 1,756 | Dominated |
| CVC-65: Tri-Annual PAP smear in ages 20-30, then Tri-annual PAP & HPV concurrent test from 30-65 with lesion removal only. | 80% | 0.95 | 5% | 95% | 214 | 4,455 | Dominated |
| CVC-66: Tri-Annual PAP smear in ages 20-30, then Tri-annual PAP & HPV concurrent test from 30-65 with lesion removal and cancer treatment | 80% | 1.10 | 1% | 99% | 1,240 | 891 | Dominated |
| CVC-67: Five Yearly PAP smear in ages 20-30, then Five Yearly PAP & HPV concurrent test from 30-65 with lesion removal only. | 80% | 0.61 | 5% | 95% | 204 | 2,978 | Dominated |
| CVC-68: Five Yearly PAP smear in ages 20-30, then Five Yearly PAP & HPV concurrent test from 30-65 with lesion removal and cancer treatment. | 80% | 0.80 | 4% | 96% | 1,227 | 651 | Dominated |
| CVC-69: PAP smear at ages 35,40,45 with lesion removal only. | 80% | 0.09 | 14% | 86% | 143 | 628 | Dominated |
| CVC-70: PAP smear at ages 35,40,45 with lesion removal and cancer treatment. | 80% | 0.42 | 3% | 97% | 1,608 | 259 | Dominated |
| CVC-71: HPV test at ages 35,40,45 with lesion removal only. | 80% | 0.32 | 4% | 96% | 157 | 2,009 | Dominated |
| CVC-72: HPV test at ages 35,40,45 with lesion removal and cancer treatment. | 80% | 0.61 | 2% | 98% | 1,568 | 386 | Dominated |
| CVC-73: VIA inspection at ages 35,40,45 with lesion removal only. | 80% | 0.12 | 10% | 90% | 153 | 797 | Dominated |
| CVC-74: VIA inspection at ages 35,40,45 with lesion removal and cancer treatment. | 80% | 0.41 | 3% | 97% | 1,565 | 264 | Dominated |
| CVC-75: PAP at age 40 with lesion removal only. | 80% | 0.04 | 21% | 79% | 93 | 400 | Dominated |
| CVC-76: PAP at age 40 with lesion removal and cancer treatment . | 80% | 0.35 | 2% | 98% | 1,564 | 222 | Dominated |
| CVC-77: HPV test at age 40 with lesion removal only. | 80% | 0.12 | 7% | 93% | 110 | 1,125 | Dominated |
| CVC-78: HPV test at age 40 with lesion removal and cancer treatment . | 80% | 0.43 | 2% | 98% | 1,577 | 272 | Dominated |
| CVC-79: WANING HPV vaccination at age 12 costing $0.60 per dose | 80% | 0.05 | 7% | 93% | 183 | 287 | Dominated |
| CVC-80: WANING HPV vaccination at age 12 costing $0.60 per dose + Rx. | 80% | 0.35 | 1% | 99% | 1,122 | 309 | Dominated |
| CVC-81: WANING HPV vaccination at age 12 costing $2.00 per dose | 80% | 0.11 | 3% | 97% | 183 | 594 | Dominated |
| CVC-82: WANING HPV vaccination at age 12 costing $2.00 per dose + Rx. | 80% | 0.41 | 1% | 99% | 1,122 | 363 | Dominated |
| CVC-83: PAP(1,20,65)+Waning HPV at age 12 costing $0.60 per dose | 80% | 0.74 | 14% | 86% | 326 | 2,283 | Dominated |
| CVC-84: PAP(3,20,65)+Waning HPV at age 12 costing $0.60 per dose | 80% | 0.50 | 9% | 91% | 310 | 1,618 | Dominated |
| CVC-85: VIA at age 40 +Waning HPV at age 12 costing $0.60 per dose | 80% | 0.09 | 10% | 90% | 225 | 417 | Dominated |
| CVC-86: PAP(1,20,65)+Waning HPV at age 12 costing $0.60 per dose+RX | 80% | 0.92 | 12% | 88% | 1,253 | 731 | Dominated |
| CVC-87: PAP(3,20,65)+Waning HPV at age 12 costing $0.60 per dose+Rx | 80% | 0.69 | 6% | 94% | 1,242 | 553 | Dominated |
| CVC-88: VIA at age 40 +Waning HPV at age 12 costing $0.60 per dose+Rx | 80% | 0.35 | 3% | 97% | 1,157 | 302 | Dominated |
| CVC-89: PAP(5,20,65)+Waning HPV at age 12 costing $0.60 per dose | 80% | 0.35 | 9% | 91% | 299 | 1,161 | Dominated |
| CVC-90: PAP(5,20,65)+Waning HPV at age 12 costing $0.60 per dose+RX | 80% | 0.55 | 5% | 95% | 1,230 | 448 | Dominated |
| CVC-91: PAP (1,20,30) & PAP/HPV(1,30,65)+Waning HPV at age 12 costing $0.60 per dose | 80% | 2.10 | 5% | 95% | 332 | 6,326 | Dominated |
| CVC-92: PAP (1,20,30) & PAP/HPV(1,30,65)+Waning HPV at age 12 costing $0.60 per dose + RX | 80% | 2.26 | 5% | 95% | 1,267 | 1,787 | Dominated |
| CVC-93: PAP (3,20,30) & PAP/HPV(3,30,65)+Waning HPV at age 12 costing $0.60 per dose | 80% | 1.00 | 4% | 96% | 319 | 3,133 | Dominated |
| CVC-94: PAP (3,20,30) & PAP/HPV(3,30,65)+Waning HPV at age 12 costing $0.60 per dose + RX | 80% | 1.17 | 4% | 96% | 1,254 | 936 | Dominated |
| CVC-95: PAP (5,20,30) & PAP/HPV(5,30,65)+Waning HPV at age 12 costing $0.60 per dose | 80% | 0.65 | 5% | 95% | 312 | 2,088 | Dominated |
| CVC-96: PAP (5,20,30) & PAP/HPV(5,30,65)+Waning HPV at age 12 costing $0.60 per dose + RX | 80% | 0.84 | 4% | 96% | 1,245 | 674 | Dominated |
| CVC-97: PAP (35,40,45)+Waning HPV at age 12 costing $0.60 per dose | 80% | 0.13 | 10% | 90% | 249 | 542 | Dominated |
| CVC-98: PAP (35,40,45)+Waning HPV at age 12 costing $0.60 per dose+Rx | 80% | 0.41 | 3% | 97% | 1,178 | 345 | Dominated |
| CVC-99: HPV (35,40,45)+Waning HPV at age 12 costing $0.60 per dose | 80% | 0.36 | 4% | 96% | 255 | 1,412 | Dominated |
| CVC-100: HPV (35,40,45)+Waning HPV at age 12 costing $0.60 per dose+Rx | 80% | 0.60 | 2% | 98% | 1,184 | 510 | Dominated |
| CVC-101: VIA (35,40,45)+Waning HPV at age 12 costing $0.60 per dose | 80% | 0.37 | 4% | 96% | 254 | 1,441 | Dominated |
| CVC-102: VIA (35,40,45)+Waning HPV at age 12 costing $0.60 per dose+Rx | 80% | 0.41 | 3% | 97% | 1,182 | 349 | Dominated |
| CVC-103: PAP at age 40 +Waning HPV at age 12 costing $0.60 per dose | 80% | 0.08 | 11% | 89% | 220 | 373 | Dominated |
| CVC-104: PAP at age 40 +Waning HPV at age 12 costing $0.60 per dose + RX | 80% | 0.34 | 3% | 97% | 1,153 | 293 | Dominated |
| CVC-105: HPV test at age 40 + waning HPV at age 12 costing $0.60 per dose | 80% | 0.17 | 5% | 95% | 227 | 736 | Dominated |
| CVC-106: HPV test at age 40 + waning HPV at age 12 costing $0.60 per dose + RX | 80% | 0.42 | 2% | 98% | 1,158 | 364 | Dominated |
| CVC-107: Annual PAP smear to persons aged 20-65 with lesion removal only. | 50% | 0.49 | 21% | 79% | 145 | 3,359 | Dominated |
| CVC-108: Tri-annual PAP smear to persons aged 20-65 with lesion removal only. | 50% | 0.39 | 11% | 89% | 125 | 3,088 | Dominated |
| CVC-109: VIA at age 40 with lesion removal only. | 50% | 0.05 | 20% | 80% | 65 | 727 | Dominated |
| CVC-110: Treatment of invasive cancer consisting of Surgery &/or Chemotherapy &/or Radiotherapy | 50% | 0.07 | 0% | 100% | 390 | 184 | Dominated |
| CVC-111: Annual PAP smear to persons aged 20-65 with lesion removal and cancer treatment | 50% | 0.55 | 17% | 83% | 646 | 855 | Dominated |
| CVC-112: Tri-annual PAP smear to persons aged 20-65 with lesion removal and cancer treatment. | 50% | 0.46 | 8% | 92% | 629 | 737 | Dominated |
| CVC-113: VIA at age 40 with lesion removal and cancer treatment. | 50% | 0.21 | 4% | 96% | 1,333 | 154 | Dominated |
| CVC-114: PAP smear every 5 years to persons aged 20-65 with lesion removal only. | 50% | 0.26 | 10% | 90% | 116 | 2,235 | Dominated |
| CVC-115: PAP smear every 5 years to persons aged 20-65 with lesion removal and cancer treatment | 50% | 0.35 | 7% | 93% | 618 | 558 | Dominated |
| CVC-116: Annual PAP smear in ages 20-30, then annual PAP & HPV concurrent test from 30-65 with lesion removal only | 50% | 1.33 | 7% | 93% | 151 | 8,787 | Dominated |
| CVC-117: Annual PAP smear in ages 20-30, then annual PAP & HPV concurrent test from 30-65 with lesion removal and cancer treatment | 50% | 1.37 | 5% | 95% | 654 | 2,100 | Dominated |
| CVC-118: Tri-Annual PAP smear in ages 20-30, then Tri-annual PAP & HPV concurrent test from 30-65 with lesion removal only. | 50% | 0.70 | 4% | 96% | 134 | 5,254 | Dominated |
| CVC-119: Tri-Annual PAP smear in ages 20-30, then Tri-annual PAP & HPV concurrent test from 30-65 with lesion removal and cancer treatment | 50% | 0.76 | 2% | 98% | 638 | 1,196 | Dominated |
| CVC-120: Five Yearly PAP smear in ages 20-30, then Five Yearly PAP & HPV concurrent test from 30-65 with lesion removal only. | 50% | 0.46 | 4% | 96% | 127 | 3,578 | Dominated |
| CVC-121: Five Yearly PAP smear in ages 20-30, then Five Yearly PAP & HPV concurrent test from 30-65 with lesion removal and cancer treatment. | 50% | 0.54 | 4% | 96% | 630 | 850 | Dominated |
| CVC-122: PAP smear at ages 35,40,45 with lesion removal only. | 50% | 0.07 | 14% | 86% | 89 | 746 | Dominated |
| CVC-123: PAP smear at ages 35,40,45 with lesion removal and cancer treatment. | 50% | 0.24 | 4% | 96% | 1,361 | 174 | Dominated |
| CVC-124: HPV test at ages 35,40,45 with lesion removal only. | 50% | 0.22 | 4% | 96% | 98 | 2,256 | Dominated |
| CVC-125: HPV test at ages 35,40,45 with lesion removal and cancer treatment. | 50% | 0.37 | 3% | 97% | 1,274 | 290 | Dominated |
| CVC-126: VIA inspection at ages 35,40,45 with lesion removal only. | 50% | 0.11 | 8% | 92% | 96 | 1,150 | Dominated |
| CVC-127: VIA inspection at ages 35,40,45 with lesion removal and cancer treatment. | 50% | 0.26 | 4% | 96% | 1,272 | 204 | Dominated |
| CVC-128: PAP at age 40 with lesion removal only. | 50% | 0.03 | 23% | 77% | 58 | 487 | Dominated |
| CVC-129: PAP at age 40 with lesion removal and cancer treatment . | 50% | 0.19 | 3% | 97% | 1,327 | 142 | 142 |
| CVC-130: HPV test at age 40 with lesion removal only. | 50% | 0.09 | 9% | 91% | 69 | 1,278 | Dominated |
| CVC-131: HPV test at age 40 with lesion removal and cancer treatment . | 50% | 0.25 | 3% | 97% | 1,336 | 184 | Dominated |
| CVC-132: WANING HPV vaccination at age 12 costing $0.60 per dose | 50% | 0.03 | 10% | 90% | 114 | 298 | Dominated |
| CVC-133: WANING HPV vaccination at age 12 costing $0.60 per dose + Rx. | 50% | 0.15 | 2% | 98% | 496 | 305 | Dominated |
| CVC-134: WANING HPV vaccination at age 12 costing $2.00 per dose | 50% | 0.07 | 5% | 95% | 114 | 605 | Dominated |
| CVC-135: WANING HPV vaccination at age 12 costing $2.00 per dose + Rx. | 50% | 0.19 | 2% | 98% | 496 | 382 | Dominated |
| CVC-136: PAP(1,20,65)+Waning HPV at age 12 costing $0.60 per dose | 50% | 0.48 | 15% | 85% | 203 | 2,380 | Dominated |
| CVC-137: PAP(3,20,65)+Waning HPV at age 12 costing $0.60 per dose | 50% | 0.40 | 8% | 92% | 193 | 2,081 | Dominated |
| CVC-138: VIA at age 40 +Waning HPV at age 12 costing $0.60 per dose | 50% | 0.07 | 11% | 89% | 141 | 518 | Dominated |
| CVC-139: PAP(1,20,65)+Waning HPV at age 12 costing $0.60 per dose+RX | 50% | 0.56 | 13% | 87% | 583 | 953 | Dominated |
| CVC-140: PAP(3,20,65)+Waning HPV at age 12 costing $0.60 per dose+Rx | 50% | 0.48 | 6% | 94% | 574 | 832 | Dominated |
| CVC-141: VIA at age 40 +Waning HPV at age 12 costing $0.60 per dose+Rx | 50% | 0.18 | 4% | 96% | 521 | 338 | Dominated |
| CVC-142: PAP(5,20,65)+Waning HPV at age 12 costing $0.60 per dose | 50% | 0.28 | 8% | 92% | 187 | 1,505 | Dominated |
| CVC-143: PAP(5,20,65)+Waning HPV at age 12 costing $0.60 per dose+RX | 50% | 0.36 | 6% | 94% | 567 | 642 | Dominated |
| CVC-144: PAP (1,20,30) & PAP/HPV(1,30,65)+Waning HPV at age 12 costing $0.60 per dose | 50% | 1.33 | 5% | 95% | 207 | 6,424 | Dominated |
| CVC-145: PAP (1,20,30) & PAP/HPV(1,30,65)+Waning HPV at age 12 costing $0.60 per dose + RX | 50% | 1.40 | 5% | 95% | 589 | 2,378 | Dominated |
| CVC-146: PAP (3,20,30) & PAP/HPV(3,30,65)+Waning HPV at age 12 costing $0.60 per dose | 50% | 0.73 | 4% | 96% | 199 | 3,673 | Dominated |
| CVC-147: PAP (3,20,30) & PAP/HPV(3,30,65)+Waning HPV at age 12 costing $0.60 per dose + RX | 50% | 0.80 | 4% | 96% | 581 | 1,384 | Dominated |
| CVC-148: PAP (5,20,30) & PAP/HPV(5,30,65)+Waning HPV at age 12 costing $0.60 per dose | 50% | 0.48 | 4% | 96% | 195 | 2,482 | Dominated |
| CVC-149: PAP (5,20,30) & PAP/HPV(5,30,65)+Waning HPV at age 12 costing $0.60 per dose + RX | 50% | 0.56 | 4% | 96% | 576 | 974 | Dominated |
| CVC-150: PAP (35,40,45)+Waning HPV at age 12 costing $0.60 per dose | 50% | 0.10 | 11% | 89% | 156 | 613 | Dominated |
| CVC-151: PAP (35,40,45)+Waning HPV at age 12 costing $0.60 per dose+Rx | 50% | 0.21 | 5% | 95% | 535 | 384 | Dominated |
| CVC-152: HPV (35,40,45)+Waning HPV at age 12 costing $0.60 per dose | 50% | 0.25 | 4% | 96% | 160 | 1,567 | Dominated |
| CVC-153: HPV (35,40,45)+Waning HPV at age 12 costing $0.60 per dose+Rx | 50% | 0.35 | 3% | 97% | 539 | 646 | Dominated |
| CVC-154: VIA (35,40,45)+Waning HPV at age 12 costing $0.60 per dose | 50% | 0.26 | 4% | 96% | 159 | 1,609 | Dominated |
| CVC-155: VIA (35,40,45)+Waning HPV at age 12 costing $0.60 per dose+Rx | 50% | 0.24 | 5% | 95% | 538 | 443 | Dominated |
| CVC-156: PAP at age 40 +Waning HPV at age 12 costing $0.60 per dose | 50% | 0.06 | 14% | 86% | 138 | 414 | Dominated |
| CVC-157: PAP at age 40 +Waning HPV at age 12 costing $0.60 per dose + RX | 50% | 0.16 | 5% | 95% | 518 | 310 | Dominated |
| CVC-158: HPV test at age 40 + waning HPV at age 12 costing $0.60 per dose | 50% | 0.11 | 7% | 93% | 142 | 810 | Dominated |
| CVC-159: HPV test at age 40 + waning HPV at age 12 costing $0.60 per dose + RX | 50% | 0.22 | 4% | 96% | 522 | 418 | Dominated |